Check the spelling or try searching for a more general term.
Ellex’s superior treatment and diagnostic solutions enable you to achieve optimum results across a wide spectrum of treatment pathways.
Find out more about how we’re able to help you secure remedial breakthroughs by deploying our technology in these areas.
Clinically proven as first-line therapy for glaucoma
Ultra low energy, ultra high definition for precision capsulotomy
Pattern scanning photocoagulation that puts you in control
A critically important diagnosis tool
Quantel Medical has completed its acquisition of Ellex, including the company’s laser and ultrasound technology solutions (with the exception of 2RT® and iTrack®), via the financial holding company Lumibird Medical.
The coming together of these two companies—both renowned in the field of ophthalmology—represents a real milestone in their history. Quantel Medical and Ellex have a shared heritage in the development of cutting-edge technologies for the diagnosis and treatment of the leading causes of blindness worldwide: glaucoma, cataracts, AMD and diabetic retinopathy.